d some 3,500 Group Health participants, average age 73, with the Adult Changes in Thought (ACT) study, which is a Group Health/UW project funded by the National Institute on Aging. The group showed for the first time a dose response; that is, that Alzheimer's risk may grow with higher use. For instance, it found people taking